Restoration of First Phase Insulin Release in Subjects With Type 2 Diabetes Mellitus With Subcutaneous Injection of 20 microg AVE0010 in a Double-Blind, Randomized, Placebo-Controlled, Two-Way Cross Over Intravenous Glucose Challenge Study.

Trial Profile

Restoration of First Phase Insulin Release in Subjects With Type 2 Diabetes Mellitus With Subcutaneous Injection of 20 microg AVE0010 in a Double-Blind, Randomized, Placebo-Controlled, Two-Way Cross Over Intravenous Glucose Challenge Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2014

At a glance

  • Drugs Lixisenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms RESTORE
  • Most Recent Events

    • 22 Feb 2012 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Actual number of patients added to 22 as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top